Clinical trials data
Digit Span Test in schizophrenia and psychosis trials: 66 registered studies
Every registered schizophrenia and psychosis study on ClinicalTrials.gov that names the Digit Span Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered schizophrenia and psychosis studies name it in an outcome measure
- 66
- Name it in a primary outcome, 23%
- 15 of 66
Tests named in the same studies
- 1
Trail Making Test27 studies, 5 as a primary outcome
- 2
Verbal Learning23 studies, 6 as a primary outcome
- 3
Verbal Fluency19 studies, 4 as a primary outcome
- 4
Symbol Coding18 studies, 3 as a primary outcome
- 5
Card Sorting Test (Berg)17 studies, 2 as a primary outcome
- 6
Continuous Performance Test15 studies, 4 as a primary outcome
- 7
Category Fluency13 studies, 2 as a primary outcome
- 8
Stroop Color-Word Test13 studies, 1 as a primary outcome
- 9
Tower Planning8 studies, 1 as a primary outcome
- 10
Letter-Number Sequencing Task6 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 3 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 3 | 2 |
| 2011 | 1 | 0 |
| 2012 | 4 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 3 | 1 |
| 2016 | 5 | 2 |
| 2017 | 4 | 0 |
| 2018 | 5 | 0 |
| 2019 | 7 | 2 |
| 2020 | 4 | 0 |
| 2021 | 4 | 1 |
| 2022 | 5 | 1 |
| 2023 | 2 | 1 |
| 2024 | 4 | 1 |
| 2025 | 2 | 1 |
| 2026 | 3 | 0 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 11 studies, 0 as a primary outcome
- Phase 212 studies, 3 as a primary outcome
- Phase 2/32 studies, 0 as a primary outcome
- Phase 33 studies, 0 as a primary outcome
- Phase 47 studies, 1 as a primary outcome
- Not applicable39 studies, 11 as a primary outcome
- Observational1 studies, 0 as a primary outcome
Participants per study
- Phase 270 median, 46 to 90
- Not applicable60 median, 36 to 80
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 12 | 70 | 46 to 90 |
| Not applicable | 39 | 60 | 36 to 80 |
When schizophrenia and psychosis trials measure it
Latest time point of each outcome
- Within a day8 outcomes, 1 as a primary outcome
- Up to 4 weeks10 outcomes, 2 as a primary outcome
- 1 to 3 months25 outcomes, 8 as a primary outcome
- 3 to 6 months14 outcomes, 2 as a primary outcome
- 6 to 12 months7 outcomes, 2 as a primary outcome
- 1 to 2 years2 outcomes, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
66 of the 66 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting12 studies, 4 as a primary outcome
- Not yet recruiting2 studies, 0 as a primary outcome
- Active, not recruiting1 studies, 0 as a primary outcome
- Completed37 studies, 8 as a primary outcome
- Stopped early2 studies, 0 as a primary outcome
- Status unknown12 studies, 3 as a primary outcome
What they test
- Behavioral21 studies, 7 as a primary outcome
- Drug28 studies, 5 as a primary outcome
- Device14 studies, 3 as a primary outcome
- Dietary supplement2 studies, 1 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Other10 studies, 1 as a primary outcome
- None given1 studies, 0 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- Taiwan18 studies, 3 as a primary outcome
- Canada6 studies, 2 as a primary outcome
- United States6 studies, 1 as a primary outcome
- Hong Kong5 studies, 3 as a primary outcome
- South Korea4 studies, 0 as a primary outcome
- France3 studies, 0 as a primary outcome
- Norway3 studies, 1 as a primary outcome
- Brazil2 studies, 0 as a primary outcome
- Denmark2 studies, 1 as a primary outcome
- Germany2 studies, 1 as a primary outcome
- Israel2 studies, 1 as a primary outcome
- Netherlands2 studies, 0 as a primary outcome
27 countries in all. A study with sites in several counts in each; 5 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed schizophrenia and psychosis studies that name the Digit Span Test: 20 of 37, 54%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed schizophrenia and psychosis studies that name the Digit Span Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 3, 8% | 776, 10% |
| Results on ClinicalTrials.gov only | 5, 14% | 1,139, 14% |
| A results paper only | 12, 32% | 1,711, 22% |
| Neither | 17, 46% | 4,327, 54% |
The 66 studies
66 studies match. 15 name the Digit Span Test in a primary outcome. Median size 60 participants. Median time to the primary outcome: 10 weeks.
Loading 66 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 3 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 3 | 2 |
| 2011 | 1 | 0 |
| 2012 | 4 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 3 | 1 |
| 2016 | 5 | 2 |
| 2017 | 4 | 0 |
| 2018 | 5 | 0 |
| 2019 | 7 | 2 |
| 2020 | 4 | 0 |
| 2021 | 4 | 1 |
| 2022 | 5 | 1 |
| 2023 | 2 | 1 |
| 2024 | 4 | 1 |
| 2025 | 2 | 1 |
| 2026 | 3 | 0 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 4, other 62. Interventional 65, observational 1.
As a primary outcomeSecondary or other outcomeThe Digit Span Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07747181 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants135 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07745140 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants66 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07633899 | Start2022 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants32 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07485751 | Start2026 | PhaseEarly phase 1 | ConditionsSchizophrenia and psychosis | Participants15 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07404085 | Start2025 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder | Participants160 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07122895 | Start2025 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07091344 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06643871 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants40 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06574360 | Start2024 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06426134 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder | Participants28 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06038955 | Start2022 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder | Participants62 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06021197 | Start2023 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05796401 | Start2023 | PhasePhase 3 | ConditionsSchizophrenia and psychosis | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05582980 | Start2020 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants60 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05341804 | Start2022 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Aging, frailty and exercise | Participants84 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05240976 | Start2022 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05100888 | Start2022 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants76 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05052853 | Start2021 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants48 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT04959201 | Start2020 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT04917302 | Start2020 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT04870996 | Start2019 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants44 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04773171 | Start2021 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants72 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04745143 | Start2018 | PhasePhase 2 | ConditionsSchizophrenia and psychosis | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT04605393 | Start2021 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Substance use and addiction | Participants36 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04545294 | Start2019 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants36 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many schizophrenia and psychosis trials use the Digit Span Test?
66 registered schizophrenia and psychosis studies on ClinicalTrials.gov name it in an outcome measure, 15 of them in a primary outcome: 10% of the condition's 640 studies with a cognitive outcome, against 10% of all of them. It is the 6th most named test in schizophrenia and psychosis trials.
Which tests do schizophrenia and psychosis trials use with the Digit Span Test?
The Trail Making Test (27 studies), Verbal Learning (23 studies) and Verbal Fluency (19 studies).
How many participants do phase 2 schizophrenia and psychosis trials that use the Digit Span Test enroll?
Half of the phase 2 studies that name it enroll 70 participants or fewer, and the middle half enroll 46 to 90. 12 of them give a size.
When do schizophrenia and psychosis trials measure the Digit Span Test?
Half of the primary outcomes that name the Digit Span Test are measured within 10 weeks of the start, and the middle half from 6 weeks to 4 months. 15 primary outcomes give a duration.
How many completed schizophrenia and psychosis trials that use the Digit Span Test have reported results?
20 of the 37 completed studies that name it, 54%, have reported results: 8 posted them on ClinicalTrials.gov, 15 have a results paper linked to the registry record, and 3 did both. The other 17 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Digit Span Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.